Rhythm Pharmaceuticals buy Bank of America Co.
Start price
01.08.23
/
50%
€20.80
Target price
01.08.24
-
Performance (%)
97.12%
End price
02.08.24
€41.00
Summary
This prediction ended on 02.08.24 with a price of €41.00. With a performance of 97.12% the BUY prediction by Bank_of_America_Co_ was a big success. Bank_of_America_Co_ has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rhythm Pharmaceuticals | -4.118% | -4.118% | 61.738% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by Bank_of_America_Co_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Bank_of_America_Co_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€50.50
07.04.25
07.04.25
€57.38
07.04.26
07.04.26
55.45%
27.02.26
27.02.26
Stopped prediction by Bank_of_America_Co_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€76.50
10.07.25
10.07.25
€80.90
10.07.26
10.07.26
2.61%
27.02.26
27.02.26